Veterinary Medicines

Benamax Flavour 20 mg tablets for dogs

Authorised
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
Benamax Flavour 20 mg tablets for dogs
Benefortin Flavour 20 mg Tabletten für Hunde
Active substance:
  • Benazepril hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    20.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Medicinal product on medical prescription for renewable delivery
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:
  • PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
  • PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
  • PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)
  • PVC/Aluminium/Polyamide blister -forming laminate with aluminium lidding foil with 7 tablets/blister. Cardboard box with 1 blister strip of 7 tablets (7 tablets) Cardboard box with 2 blister strips of 7 tablets (14 tablets) Cardboard box with 4 blister strips of 7 tablets (28 tablets) Cardboard box with 10 blister strips of 7 tablets (70 tablets)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Pharmaceuticals Ltd.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-01033
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0113/003
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • France
  • Germany
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 20/04/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 16/11/2020
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/10/2020
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."